Moreover, NPTX2 was proposed as an unrecognized prognostic biomarker and target in human neuroblastoma [40], and a risky methylated gene in glioblastoma [44], even though its methylation was not investigated in RCC yet. The gene discussed is NPTX2; the disease is renal cell carcinoma.